A total of 44C45 patients per arm did not receive any prior therapy. currently being tested in the neoadjuvant and adjuvant settings to identify patients who may Dihydroberberine benefit from this therapy. This review focuses on the mechanism of action, early and late-phase Rabbit Polyclonal to DDX55 clinical trials, and Continue Reading